Is Corvus Pharmaceuticals, Inc. (CRVS) a Buy, Sell, or Hold?
NASDAQ : CRVS
Corvus Pharmaceuticals, Inc.
$14.9 USD
$0.63 (4.41%)
- Volume
- 773.45K
- Average Volume
- 1.6M
- Market Capitalization
- $1.25B
- P/E Ratio
- -27.09
- Dividend Yield
- 0.00%
- Price Target
- $31.00
- Year High
- $26.95
- Year Low
- $3.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.81
CRVS vs. The Competition
| Properties | CRVS | ABSI | AKBA | CMPX |
|---|---|---|---|---|
| Market Cap | $1.25B | $1.41B | $359.47M | $283.49M |
| Shares Outstanding | $84.09M | $169.4M | $268.26M | $138.29M |
| P/E Ratio | -27.09 | -9.99 | -17.38 | -4.82 |
| EPS | -0.49 | -0.77 | -0.08 | -0.37 |
| Day Low | 13.9 | 7.58 | 1.34 | 2.01 |
| Day High | 15.2 | 8.54 | 1.405 | 2.12 |
| Year Low | 3.96 | 2.24 | 0.823 | 1.61 |
| Year High | 26.95 | 12.055 | 4.04 | 6.88 |
| Average Price 50 | 13.4323 | 7.5981 | 1.12124 | 2.0772 |
| Average Price 200 | 12.6042 | 4.41115 | 1.55999 | 4.3135 |
| Volume | 773.45K | 3.71M | 2.5M | 2.13M |
| Average Volume | - | - | - | - |